TaiwanJ Pharmaceuticals Co., Ltd.(TW:6549)
NT$6.250.00 (0.00%)
TW:6549
TaiwanJ Pharmaceuticals Co., Ltd. financials statements
NT$6.25
At close:0.00 (0.00%)
TaiwanJ Pharmaceuticals Co., Ltd. (6549) Financial Statements
TaiwanJ Pharmaceuticals Co., Ltd. Financial Overview
TaiwanJ Pharmaceuticals Co., Ltd.'s market cap is currently NT$500.76M. The company's EPS TTM is NT$-0.23; its P/E ratio is -26.73; TaiwanJ Pharmaceuticals Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 0.00 | NT$ 0.00 | NT$ 22.74M | NT$ 15.36M | NT$ 22.06M |
| Gross Profit | NT$ -1.61M | NT$ -1.89M | NT$ 22.74M | NT$ -59.92M | NT$ 22.06M |
| Operating Income | NT$ -25.21M | NT$ -26.96M | NT$ -6.61M | NT$ -96.39M | NT$ -9.72M |
| EBITDA | NT$ -23.61M | NT$ -20.44M | NT$ -1.74M | NT$ -15.99M | NT$ -9.15M |
| Net Income | NT$ -24.34M | NT$ -22.34M | NT$ -6.05M | NT$ -92.47M | NT$ -12.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 67.82M | NT$ 87.61M | NT$ 58.83M | NT$ 60.69M | NT$ 82.88M |
| Total Assets | NT$ 77.25M | NT$ 100.77M | NT$ 73.56M | NT$ 79.79M | NT$ 170.33M |
| Total Debt | NT$ 1.79M | NT$ 472.00K | NT$ 1.17M | NT$ 1.86M | NT$ 331.00K |
| Net Debt | NT$ -66.04M | NT$ -47.13M | NT$ -57.66M | NT$ -58.83M | NT$ -82.55M |
| Total Liabilities | NT$ 6.33M | NT$ 5.71M | NT$ 6.62M | NT$ 8.19M | NT$ 6.85M |
| Stockholders' Equity | NT$ 70.92M | NT$ 95.05M | NT$ 66.94M | NT$ 71.60M | NT$ 163.48M |
| Cash Flow | |||||
| Free Cash Flow | NT$ -22.82M | NT$ -22.62M | NT$ -2.26M | NT$ -22.30M | NT$ -10.05M |
| Operating Cash Flow | NT$ -22.54M | NT$ -22.62M | NT$ -821.00K | NT$ -21.07M | NT$ -10.05M |
| Investing Cash Flow | NT$ 44.22M | NT$ -37.90M | NT$ -351.00K | NT$ -557.00K | NT$ 38.00K |
| Financing Cash Flow | NT$ -744.00K | NT$ 49.30M | NT$ -687.00K | NT$ -561.00K | NT$ -559.00K |
Currency in TWD

